![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
PROTON Study: PSI-7977 QD with PEG/RBV:
12-week Safety, RVR, cEVR, & SVR12 in
Treatment-naïve Patients with HCV GT2 or GT3
|
|
|
Reported by Jules Levin
EASL 2011 Berlin March 31-April 3
J Lalezari, E Lawitz, M Rodriguez-Torres, A Sheikh,
B Freilich, DR Nelson, T Hassanein, M Mader,
R Hyland, E Albanis, WT Symonds, MM Berrey
![croi1.gif](../images/040111/040111-7/croi1.gif)
![croi2.gif](../images/040111/040111-7/croi2.gif)
![croi3.gif](../images/040111/040111-7/croi3.gif)
![croi4.gif](../images/040111/040111-7/croi4.gif)
![croi5.gif](../images/040111/040111-7/croi5.gif)
![croi6.gif](../images/040111/040111-7/croi6.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|